BIOA - BioAmber Stock Price, News & Analysis

$0.45 0.01 (2.27 %)
(As of 11/23/2017 06:22 AM ET)
Previous Close$0.44
Today's Range$0.43 - $0.45
52-Week Range$0.32 - $6.35
Volume430,500 shs
Average Volume947,201 shs
Market Capitalization$22.71 million
P/E RatioN/A
Dividend YieldN/A
Beta2.74

About BioAmber (NYSE:BIOA)

BioAmber logoBioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., is an industrial biotechnology company, which produces sustainable chemicals. The Company's technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products. Its geographical segments include Europe and North America. Its product pipeline includes the derivatives of bio-succinic acid, such as 1,4 Butanediol (1,4 BDO) and tetrahydrofuran (THF), and succinic acid-based polyesters, and C6 building block chemicals, such as adipic acid, caprolactam and hexamethylenediamine (HMDA). Its products are used in various applications, including polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, carpets, engineering plastics and artificial leather products.


Industry, Sector and Symbol

Industry Specialty Chemicals
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSE:BIOA
CUSIPN/A

Debt

Debt-to-Equity Ratio0.24%
Current Ratio1.08%
Quick Ratio0.75%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$8.27 million
Price / Sales2.84
Cash FlowN/A
Price / CashN/A
Book Value$2.05 per share
Price / Book0.22

Dividend

Annual DividendN/A
Dividend YieldN/A

Profitability

Trailing EPS($0.75)
Net Income$-22,470,000.00
Net Margins-238.43%
Return on Equity-48.72%
Return on Assets-22.92%

Miscellaneous

Employees86
Outstanding Shares52,120,000

Frequently Asked Questions for BioAmber (NYSE:BIOA)

What is BioAmber's stock symbol?

BioAmber trades on the New York Stock Exchange (NYSE) under the ticker symbol "BIOA."

How were BioAmber's earnings last quarter?

BioAmber Inc. (NYSE:BIOA) posted its quarterly earnings data on Tuesday, August, 9th. The biotechnology company reported ($0.25) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.27) by $0.02. The biotechnology company earned $2.50 million during the quarter, compared to the consensus estimate of $2.37 million. BioAmber had a negative net margin of 238.43% and a negative return on equity of 48.72%. View BioAmber's Earnings History.

When will BioAmber make its next earnings announcement?

BioAmber is scheduled to release their next quarterly earnings announcement on Thursday, March, 15th 2018. View Earnings Estimates for BioAmber.

Where is BioAmber's stock going? Where will BioAmber's stock price be in 2017?

2 analysts have issued 12-month target prices for BioAmber's stock. Their forecasts range from $1.00 to $12.00. On average, they expect BioAmber's share price to reach $6.50 in the next year. View Analyst Ratings for BioAmber.

Are investors shorting BioAmber?

BioAmber saw a increase in short interest in October. As of October 31st, there was short interest totalling 4,811,928 shares, an increase of 111.4% from the October 13th total of 2,276,412 shares. Based on an average trading volume of 3,835,155 shares, the short-interest ratio is presently 1.3 days. Approximately 11.3% of the company's stock are sold short.

Who are some of BioAmber's key competitors?

Who are BioAmber's key executives?

BioAmber's management team includes the folowing people:

  • Raymond J. Land, Chairman of the Board (Age 72)
  • Richard P. Eno, Chief Financial Officer, Director
  • Mario Settino, Chief Financial Officer
  • Michael A. Hartmann, Executive Vice President (Age 48)
  • James Millis, Chief Technology Officer (Age 59)
  • Robert Frost, Director
  • Kurt W. Briner, Independent Director (Age 70)
  • Heinz Haller, Independent Director (Age 62)
  • Ellen B. Richstone, Independent Director (Age 65)
  • Kenneth W Wall, Independent Director (Age 66)

Who owns BioAmber stock?

BioAmber's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Robecosam AG (2.84%). Company insiders that own BioAmber stock include George Frederick John Gosbee, Jean-Francois Huc, Kenneth W Wall, Kurt W Briner, Mario Settino and Michael A Hartmann. View Institutional Ownership Trends for BioAmber.

Who bought BioAmber stock? Who is buying BioAmber stock?

BioAmber's stock was acquired by a variety of institutional investors in the last quarter, including Robecosam AG. Company insiders that have bought BioAmber stock in the last two years include George Frederick John Gosbee, Jean-Francois Huc, Kenneth W Wall, Kurt W Briner, Mario Settino and Michael A Hartmann. View Insider Buying and Selling for BioAmber.

How do I buy BioAmber stock?

Shares of BioAmber can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BioAmber's stock price today?

One share of BioAmber stock can currently be purchased for approximately $0.45.

How big of a company is BioAmber?

BioAmber has a market capitalization of $22.71 million and generates $8.27 million in revenue each year. The biotechnology company earns $-22,470,000.00 in net income (profit) each year or ($0.75) on an earnings per share basis. BioAmber employs 86 workers across the globe.

How can I contact BioAmber?

BioAmber's mailing address is 1250 Rene Levesque West Suite 4310, Montreal A8, H3B 4W8. The biotechnology company can be reached via phone at 514-844-8000 or via email at [email protected]


MarketBeat Community Rating for BioAmber (BIOA)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  112 (Vote Outperform)
Underperform Votes:  81 (Vote Underperform)
Total Votes:  193
MarketBeat's community ratings are surveys of what our community members think about BioAmber and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for BioAmber (NYSE:BIOA)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 1 Hold Rating, 1 Buy Rating, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $6.50 (1,344.44% upside)

Consensus Price Target History for BioAmber (NYSE:BIOA)

Price Target History for BioAmber (NYSE:BIOA)

Analysts' Ratings History for BioAmber (NYSE:BIOA)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/10/2017Cowen and CompanyReiterated RatingHold$1.00N/AView Rating Details
11/8/2017HC WainwrightReiterated RatingBuy$12.00N/AView Rating Details
3/13/2017AltaCorp CapitalDowngradeOutperform -> SpeculativeMediumView Rating Details
8/7/2016Canaccord GenuityReiterated RatingBuy$5.50N/AView Rating Details
3/28/2016Credit Suisse GroupBoost Price TargetOutperform$15.00 -> $17.00N/AView Rating Details
1/5/2016Rodman & RenshawInitiated CoverageBuy$18.00N/AView Rating Details
(Data available from 11/23/2015 forward)

Earnings

Earnings History and Estimates Chart for BioAmber (NYSE:BIOA)

Earnings by Quarter for BioAmber (NYSE:BIOA)

Earnings History by Quarter for BioAmber (NYSE BIOA)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/15/2018        
8/3/20176/30/2017($0.17)($0.20)$4.09 million$4.12 millionViewListenView Earnings Details
5/9/20173/31/2017($0.13)($0.31)$3.65 million$2.12 millionViewListenView Earnings Details
3/16/201712/31/2016($0.19)($0.31)$3.77 million$0.63 millionViewN/AView Earnings Details
11/3/2016Q216($0.22)($0.26)$3.75 million$3.66 millionViewN/AView Earnings Details
8/9/2016Q116($0.27)($0.25)$2.37 million$2.50 millionViewN/AView Earnings Details
3/14/2016Q415($0.35)($0.40)$0.98 million$1.11 millionViewN/AView Earnings Details
11/4/2015Q315($0.41)($0.27)$2.30 million$0.35 millionViewN/AView Earnings Details
3/12/2015Q414($0.39)($0.48)($0.31) millionViewN/AView Earnings Details
11/6/2014Q3 2014($0.40)($0.41)$0.47 millionViewN/AView Earnings Details
8/7/2014Q2 2014($0.40)$0.40$0.45 million$0.42 millionViewN/AView Earnings Details
3/13/2014($0.36)($0.45)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for BioAmber (NYSE:BIOA)
Current Year EPS Consensus Estimate: $-0.53 EPS
Next Year EPS Consensus Estimate: $-0.28 EPS

Dividends

Dividend History for BioAmber (NYSE:BIOA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for BioAmber (NYSE BIOA)

Insider Ownership Percentage: 8.33%
Institutional Ownership Percentage: 44.42%
Insider Trades by Quarter for BioAmber (NYSE:BIOA)
Institutional Ownership by Quarter for BioAmber (NYSE:BIOA)

Insider Trades by Quarter for BioAmber (NYSE BIOA)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/18/2017Michael A HartmannInsiderBuy10,000$0.48$4,800.00View SEC Filing  
8/9/2017Mario SettinoCFOBuy15,000$0.53$7,950.00View SEC Filing  
11/9/2016George Frederick John GosbeeDirectorBuy25,000$3.87$96,750.00View SEC Filing  
11/8/2016Kurt W BrinerDirectorBuy10,000$3.84$38,400.00View SEC Filing  
5/24/2016Kurt W BrinerDirectorBuy1,000$3.69$3,690.00View SEC Filing  
5/23/2016Kurt W BrinerDirectorBuy21,015$3.61$75,864.15View SEC Filing  
5/11/2016Jean-Francois HucCEOBuy10,000$3.22$32,200.00View SEC Filing  
5/9/2016Kenneth W WallDirectorBuy13,227$3.11$41,135.97View SEC Filing  
5/6/2016Michael A HartmannEVPBuy3,000$3.44$10,320.00View SEC Filing  
12/3/2015Jean-Francois HucCEOSell27,278$8.11$221,224.58View SEC Filing  
12/3/2015Michael A. HartmannEVPSell21,477$8.11$174,178.47View SEC Filing  
8/14/2015Michael A HartmannEVPBuy1,500$6.75$10,125.00View SEC Filing  
8/11/2015Jean-Francois HucCEOBuy4,000$6.18$24,720.00View SEC Filing  
8/10/2015Raymond J LandDirectorBuy1,500$6.71$10,065.00View SEC Filing  
5/6/2015Jean-Francois HucCEOBuy8,800$9.00$79,200.00View SEC Filing  
5/6/2015Kurt W BrinerDirectorBuy10,000$9.00$90,000.00View SEC Filing  
5/6/2015Michael A HartmannEVPBuy1,100$9.00$9,900.00View SEC Filing  
12/11/2014Kenneth W WallDirectorBuy3,000$9.20$27,600.00View SEC Filing  
12/10/2014Kenneth W WallDirectorBuy5,000$9.30$46,500.00View SEC Filing  
11/10/2014Kurt W BrinerDirectorBuy15,000$9.35$140,250.00View SEC Filing  
9/9/2014Kurt W BrinerDirectorBuy5,000$12.00$60,000.00View SEC Filing  
8/25/2014Kurt W BrinerDirectorBuy14,250$11.50$163,875.00View SEC Filing  
8/11/2014Kurt W BrinerDirectorBuy2,980$11.45$34,121.00View SEC Filing  
7/16/2014Jean-Francois HucCEOBuy4,000$12.00$48,000.00View SEC Filing  
7/16/2014Michael A HartmannEVPBuy3,000$12.00$36,000.00View SEC Filing  
5/12/2014Andrew P AshworthCFOBuy3,000$10.00$30,000.00View SEC Filing  
5/12/2014Michael A HartmannEVPBuy2,500$10.05$25,125.00View SEC Filing  
11/14/2013Kurt W BrinerDirectorBuy7,200$6.95$50,040.00View SEC Filing  
9/3/2013Michael A HartmannEVPBuy2,000$4.63$9,260.00View SEC Filing  
8/29/2013Jean-Francois HucCEOBuy5,000$4.25$21,250.00View SEC Filing  
8/15/2013Kurt W BrinerDirectorBuy13,000$5.49$71,370.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for BioAmber (NYSE BIOA)

Source:
DateHeadline
Contrasting Trinseo (TSE) & BioAmber (BIOA)Contrasting Trinseo (TSE) & BioAmber (BIOA)
www.americanbankingnews.com - November 23 at 3:12 AM
 BioAmber Inc. (BIOA) Given Consensus Recommendation of "Buy" by Analysts BioAmber Inc. (BIOA) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - November 17 at 7:12 PM
Short Interest in BioAmber Inc. (BIOA) Expands By 111.4%Short Interest in BioAmber Inc. (BIOA) Expands By 111.4%
www.americanbankingnews.com - November 16 at 1:34 AM
Edited Transcript of BIOA earnings conference call or presentation 7-Nov-17 9:30pm GMTEdited Transcript of BIOA earnings conference call or presentation 7-Nov-17 9:30pm GMT
finance.yahoo.com - November 11 at 9:26 PM
BioAmber Inc. (BIOA) Stock Rating Reaffirmed by Cowen and CompanyBioAmber Inc. (BIOA) Stock Rating Reaffirmed by Cowen and Company
www.americanbankingnews.com - November 11 at 10:22 AM
HC Wainwright Reiterates "Buy" Rating for BioAmber Inc. (BIOA)HC Wainwright Reiterates "Buy" Rating for BioAmber Inc. (BIOA)
www.americanbankingnews.com - November 8 at 11:10 PM
BioAmber Announces Third Quarter 2017 Financial Results - PR Newswire (press release)BioAmber Announces Third Quarter 2017 Financial Results - PR Newswire (press release)
www.prnewswire.com - November 8 at 7:08 PM
BioAmbers (BIOA) CEO Rick Eno on Q3 2017 Results - Earnings Call TranscriptBioAmber's (BIOA) CEO Rick Eno on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 8 at 12:21 AM
BioAmber Announces Third Quarter 2017 Financial ResultsBioAmber Announces Third Quarter 2017 Financial Results
finance.yahoo.com - November 7 at 7:18 PM
BioAmber reports 3Q lossBioAmber reports 3Q loss
finance.yahoo.com - November 7 at 7:18 PM
Valvoline (VVV) versus BioAmber (BIOA) Financial SurveyValvoline (VVV) versus BioAmber (BIOA) Financial Survey
www.americanbankingnews.com - November 7 at 3:28 AM
Pre-market Technical Pulse on Chemicals Stocks -- BioAmber, Celanese, DowDuPont, and Eastman ChemicalPre-market Technical Pulse on Chemicals Stocks -- BioAmber, Celanese, DowDuPont, and Eastman Chemical
www.bizjournals.com - October 30 at 10:41 PM
BioAmber Announces Webcast of Fiscal Third Quarter 2017 Financial ResultsBioAmber Announces Webcast of Fiscal Third Quarter 2017 Financial Results
finance.yahoo.com - October 27 at 6:54 PM
BioAmber Inc. (BIOA) Set to Announce Earnings on WednesdayBioAmber Inc. (BIOA) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - October 25 at 6:30 AM
BioAmber President and COO Steps Down - PR Newswire (press release)BioAmber President and COO Steps Down - PR Newswire (press release)
www.prnewswire.com - October 25 at 4:41 AM
BioAmber President and COO Steps DownBioAmber President and COO Steps Down
finance.yahoo.com - October 24 at 6:33 PM
Reviewing BioAmber (BIOA) & Valvoline (VVV)Reviewing BioAmber (BIOA) & Valvoline (VVV)
www.americanbankingnews.com - October 23 at 4:32 PM
BioAmber Inc. (BIOA) Short Interest Up 42.9% in SeptemberBioAmber Inc. (BIOA) Short Interest Up 42.9% in September
www.americanbankingnews.com - October 17 at 1:04 AM
How Does Investing In BioAmber Inc (BIOA) Impact Your Portfolio?How Does Investing In BioAmber Inc (BIOA) Impact Your Portfolio?
finance.yahoo.com - October 10 at 5:51 PM
How Does Investing In BioAmber Inc (BIOA) Impact Your Portfolio?How Does Investing In BioAmber Inc (BIOA) Impact Your Portfolio?
finance.yahoo.com - October 10 at 5:51 PM
Reviewing Innospec (IOSP) & BioAmber (BIOA)Reviewing Innospec (IOSP) & BioAmber (BIOA)
www.americanbankingnews.com - September 19 at 12:48 AM
Form 8-K BioAmber Inc. For: Sep 11 - StreetInsider.comForm 8-K BioAmber Inc. For: Sep 11 - StreetInsider.com
www.streetinsider.com - September 16 at 4:15 PM
BioAmber Announces New Chief Executive OfficerBioAmber Announces New Chief Executive Officer
finance.yahoo.com - September 14 at 5:14 PM
Analyzing BioAmber (BIOA) and Its RivalsAnalyzing BioAmber (BIOA) and Its Rivals
www.americanbankingnews.com - September 13 at 6:22 PM
BioAmber Inc. Receives Notice of Non-Compliance from the NYSEBioAmber Inc. Receives Notice of Non-Compliance from the NYSE
finance.yahoo.com - September 13 at 5:42 PM
BRIEF-Sabby Management LLC reports 6.15 pct passive stake in BioAmber inc - SEC filing‍BRIEF-Sabby Management LLC reports 6.15 pct passive stake in BioAmber inc - SEC filing‍
www.reuters.com - September 13 at 3:07 AM
Form SC 13G BioAmber Inc. Filed by: SABBY MANAGEMENT, LLC - StreetInsider.comForm SC 13G BioAmber Inc. Filed by: SABBY MANAGEMENT, LLC - StreetInsider.com
www.streetinsider.com - September 12 at 4:50 PM
BRIEF-NN Group N.V. reports 15.91 pct passive stake in BioamberBRIEF-NN Group N.V. reports 15.91 pct passive stake in Bioamber
www.reuters.com - September 8 at 10:00 PM
Kronos Worldwide (KRO) versus BioAmber (BIOA) Head-To-Head ReviewKronos Worldwide (KRO) versus BioAmber (BIOA) Head-To-Head Review
www.americanbankingnews.com - September 2 at 2:26 AM
BioAmber, Inc. :BIOA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017BioAmber, Inc. :BIOA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 25 at 6:18 PM
Head to Head Review: Ferro Corporation (FOE) versus BioAmber (BIOA)Head to Head Review: Ferro Corporation (FOE) versus BioAmber (BIOA)
www.americanbankingnews.com - August 14 at 12:52 PM
BioAmber (BIOA) Prices $11M Offering of Common Stock, WarrantsBioAmber (BIOA) Prices $11M Offering of Common Stock, Warrants
www.streetinsider.com - August 8 at 9:23 PM
BRIEF-Bioamber prices public offering of 14.7 mln shares at $0.75/shrBRIEF-Bioamber prices public offering of 14.7 mln shares at $0.75/shr
www.reuters.com - August 8 at 9:23 PM
Mid-Afternoon Market Update: Michael Kors Gains On Earnings Beat; Commercial Vehicle Shares Slide - NasdaqMid-Afternoon Market Update: Michael Kors Gains On Earnings Beat; Commercial Vehicle Shares Slide - Nasdaq
www.nasdaq.com - August 8 at 4:20 PM
Mid-Day Market Update: Stocks Turn Higher; Depomed Shares Plummet - NasdaqMid-Day Market Update: Stocks Turn Higher; Depomed Shares Plummet - Nasdaq
www.nasdaq.com - August 8 at 4:20 PM
BioAmber Inc. Announces US$11 Million Underwritten Offering of Common Stock and Warrants - MarketWatchBioAmber Inc. Announces US$11 Million Underwritten Offering of Common Stock and Warrants - MarketWatch
www.marketwatch.com - August 8 at 4:20 PM
BioAmber Inc. Announces US$11 Million Underwritten Offering of Common Stock and WarrantsBioAmber Inc. Announces US$11 Million Underwritten Offering of Common Stock and Warrants
finance.yahoo.com - August 8 at 4:20 PM
BioAmber Inc. Announces Underwritten Offering of Common Stock and Warrants - MarketWatchBioAmber Inc. Announces Underwritten Offering of Common Stock and Warrants - MarketWatch
www.marketwatch.com - August 8 at 3:05 AM
BioAmber (BIOA) Announces Underwritten Common OfferingBioAmber (BIOA) Announces Underwritten Common Offering
www.streetinsider.com - August 7 at 10:05 PM
BRIEF-BioAmber announces underwritten offering of common stock and warrantsBRIEF-BioAmber announces underwritten offering of common stock and warrants
www.reuters.com - August 7 at 5:04 PM
BioAmber Inc. Announces Underwritten Offering of Common Stock and WarrantsBioAmber Inc. Announces Underwritten Offering of Common Stock and Warrants
finance.yahoo.com - August 7 at 5:04 PM
BioAmbers (BIOA) Management on Q2 2017 Results - Earnings Call Transcript - Seeking AlphaBioAmber's (BIOA) Management on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 6 at 4:02 PM
BioAmber announces record revenues for the second quarter 2017 and purchase of Mitsui equity stake in Sarnia Joint ... - PR Newswire (press release)BioAmber announces record revenues for the second quarter 2017 and purchase of Mitsui equity stake in Sarnia Joint ... - PR Newswire (press release)
www.prnewswire.com - August 4 at 9:50 PM
BioAmber Inc. (BIOA) Issues  Earnings ResultsBioAmber Inc. (BIOA) Issues Earnings Results
www.americanbankingnews.com - August 4 at 8:58 PM
Edited Transcript of BIOA earnings conference call or presentation 3-Aug-17 12:30pm GMTEdited Transcript of BIOA earnings conference call or presentation 3-Aug-17 12:30pm GMT
finance.yahoo.com - August 3 at 11:02 PM
Investor Network: BioAmber, Inc. to Host Earnings CallInvestor Network: BioAmber, Inc. to Host Earnings Call
finance.yahoo.com - August 3 at 6:01 PM
BioAmber announces record revenues for the second quarter 2017 and purchase of Mitsui equity stake in Sarnia Joint VentureBioAmber announces record revenues for the second quarter 2017 and purchase of Mitsui equity stake in Sarnia Joint Venture
finance.yahoo.com - August 3 at 6:01 PM
BioAmber reports 2Q lossBioAmber reports 2Q loss
finance.yahoo.com - August 3 at 6:01 PM
BioAmber Announces Webcast of Fiscal Second Quarter 2017 Financial ResultsBioAmber Announces Webcast of Fiscal Second Quarter 2017 Financial Results
finance.yahoo.com - August 1 at 5:25 PM
BioAmber Inc. (BIOA) Set to Announce Earnings on MondayBioAmber Inc. (BIOA) Set to Announce Earnings on Monday
www.americanbankingnews.com - July 31 at 8:11 AM

Social Media

Financials

Chart

BioAmber (NYSE BIOA) Chart for Thursday, November, 23, 2017
Loading chart…

This page was last updated on 11/23/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.